Publication | Closed Access

On reducing the risk of vaccine-associated paralytic poliomyelitis in the global transition from oral to inactivated poliovirus vaccine

VaccinationCell-based Vaccine ProductionVaccine SafetyVaccine DevelopmentVaccine-associated Paralytic PoliomyelitisVaccine TargetGlobal TransitionImmunologyVirologyInactivated Poliovirus VaccinePublic HealthPolioMedicineEpidemiology